Gene · 4929
Papers4,115
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,115
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adult human subventricular zone microglia promote a pro-neurogenic niche for neuronal progenitors in Parkinson's disease. | Brain Behav Immun | 2025 | 40516636 | PubTator, text mining | PubMed |
| Expanding the Clinical Spectrum of NR4A2-Related Disorder: A Systematic Literature Review and Case Series. | Am J Med Genet A | 2025 | 40497586 | PubTator, text mining | PubMed |
| Bridging prediction and reality: Comprehensive analysis of experimental and AlphaFold 2 full-length nuclear receptor structures. | Comput Struct Biotechnol J | 2025 | 40496892 | PubTator, text mining | PubMed |
| Nurr1 modulators - a patent review (2019-present). | Expert Opin Ther Pat | 2025 | 40481732 | PubTator, text mining | PubMed |
| Characterization of m6A-Related Genes in Tumor-Associated Macrophages for Prognosis, Immunotherapy, and Drug Prediction in Lung Adenocarcinomas Based on Machine Learning Algorithms. | FASEB J | 2025 | 40474570 | PubTator, text mining | PubMed |
| Retinoid X Receptor as a Therapeutic Target to Treat Neurological Disorders Associated with α-Synucleinopathy. | Cells | 2025 | 40422188 | PubTator, text mining | PubMed |
| CellWalker2: Multi-omic discovery using hierarchical cell type relationships. | Cell Genom | 2025 | 40409272 | PubTator, text mining | PubMed |
| Structural and mechanistic profiling of Nurr1 modulation by vidofludimus enables structure-guided ligand design. | Commun Chem | 2025 | 40399628 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs: gatekeepers of inflammation in autoimmune disease. | J Inflamm (Lond) | 2025 | 40369549 | PubTator, text mining | PubMed |
| Transcriptional evidence of reduced BDNF trophic capacity in the post-mortem human midbrain of schizophrenia cases with high inflammation. | Transl Psychiatry | 2025 | 40335479 | PubTator, text mining | PubMed |
| Expression of Prooncogenic Nuclear Receptor 4A (NR4A)-Regulated Genes β1-Integrin and G9a Inhibited by Dual NR4A1/2 Ligands. | Int J Mol Sci | 2025 | 40332813 | PubTator, text mining | PubMed |
| Alpha-Synuclein drives NURR1 and NLRP3 Inflammasome dysregulation in Parkinson's disease: From pathogenesis to potential therapeutic strategies. | Int Immunopharmacol | 2025 | 40267723 | PubTator, text mining | PubMed |
| Development of In Vitro Parkinson's Disease Model Mediated by MPP+ and α-Synuclein Using Wharton's Jelly Mesenchymal Stem Cells. | CNS Neurosci Ther | 2025 | 40260646 | PubTator, text mining | PubMed |
| Correction: Molecular basis of ligand-dependent Nurr1-RXRα activation. | Elife | 2025 | 40227840 | PubTator, text mining | PubMed |
| Genetic variants associated with idiopathic Parkinson's disease in Latin America: A systematic review. | Neurogenetics | 2025 | 40178685 | PubTator, text mining | PubMed |
| Towards a unified molecular mechanism for liganddependent activation of NR4A-RXR heterodimers. | bioRxiv | 2025 | 40166180 | PubTator, text mining | PubMed |
| The Organogermanium Compound 3-(trihydroxygermyl)propanoic Acid Exerts Anti-Inflammatory Effects via Adenosine-NR4A2 Signaling. | Int J Mol Sci | 2025 | 40141094 | PubTator, text mining | PubMed |
| Neurotoxic Effects of Atrazine on Dopaminergic System via miRNAs and Energy-Sensing Pathways. | Mol Neurobiol | 2025 | 40085354 | PubTator, text mining | PubMed |
| Clinical and genetic findings in autism spectrum disorders analyzed using exome sequencing. | Front Psychiatry | 2025 | 40071278 | PubTator, text mining | PubMed |
| Retinoid X Receptor as a Therapeutic Target to Treat Neurological Disorders Associated with α -Synucleinopathy. | bioRxiv | 2025 | 40060585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4929/papers?page=7